P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

• Yu Yagi,
• Yusuke Kanemasa,
• Yuki Sasaki,
• Kento Ishimine,
• Yudai Hayashi,
• Mano Mino,
• An Ohigashi,
• Yuka Morita,
• Taichi Tamura,
• Shohei Nakamura,
• Toshihiro Okuya,
• Tatsu Shimoyama

Affiliations

Yu Yagi

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Yusuke Kanemasa

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Yuki Sasaki

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Kento Ishimine

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Yudai Hayashi

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Mano Mino

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

An Ohigashi

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Yuka Morita

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Taichi Tamura

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Shohei Nakamura

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Toshihiro Okuya

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan

Tatsu Shimoyama

1 Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, Medical Oncology, Tokyo, Japan